The Ensign Group, Inc. $ENSG Shares Acquired by Onex Canada Asset Management Inc.

Onex Canada Asset Management Inc. increased its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 30.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 76,483 shares of the company’s stock after acquiring an additional 17,972 shares during the period. The Ensign Group makes up approximately 1.7% of Onex Canada Asset Management Inc.’s portfolio, making the stock its 19th biggest holding. Onex Canada Asset Management Inc.’s holdings in The Ensign Group were worth $13,214,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Baillie Gifford & Co. lifted its holdings in The Ensign Group by 96.2% in the third quarter. Baillie Gifford & Co. now owns 2,818,609 shares of the company’s stock valued at $486,971,000 after acquiring an additional 1,382,035 shares during the period. Norges Bank purchased a new stake in shares of The Ensign Group during the 2nd quarter worth $105,400,000. Victory Capital Management Inc. grew its stake in shares of The Ensign Group by 195.4% during the 3rd quarter. Victory Capital Management Inc. now owns 513,328 shares of the company’s stock worth $88,688,000 after purchasing an additional 339,534 shares during the period. Wasatch Advisors LP grew its stake in shares of The Ensign Group by 6.0% during the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock worth $548,961,000 after purchasing an additional 199,983 shares during the period. Finally, Hood River Capital Management LLC increased its holdings in shares of The Ensign Group by 61.4% in the 2nd quarter. Hood River Capital Management LLC now owns 492,016 shares of the company’s stock valued at $75,898,000 after purchasing an additional 187,262 shares in the last quarter. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Trading Up 0.6%

Shares of The Ensign Group stock opened at $209.71 on Friday. The Ensign Group, Inc. has a 1 year low of $118.73 and a 1 year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.42 and a quick ratio of 1.42. The business has a 50 day moving average price of $194.20 and a 200 day moving average price of $182.89. The company has a market capitalization of $12.15 billion, a P/E ratio of 35.91, a P/E/G ratio of 2.04 and a beta of 0.83.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Wednesday, February 4th. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.07. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The Ensign Group’s quarterly revenue was up 20.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.49 EPS. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. Sell-side analysts anticipate that The Ensign Group, Inc. will post 5.59 EPS for the current fiscal year.

The Ensign Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, January 31st. Investors of record on Wednesday, December 31st were paid a dividend of $0.065 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This is an increase from The Ensign Group’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The Ensign Group’s dividend payout ratio is 4.45%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ENSG. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Zacks Research upgraded shares of The Ensign Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 26th. Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 6th. Royal Bank Of Canada reissued an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, The Ensign Group currently has an average rating of “Buy” and a consensus target price of $204.60.

Insider Activity

In related news, Director John O. Agwunobi sold 146 shares of The Ensign Group stock in a transaction dated Wednesday, January 21st. The stock was sold at an average price of $178.31, for a total transaction of $26,033.26. Following the completion of the sale, the director owned 9,087 shares in the company, valued at approximately $1,620,302.97. This trade represents a 1.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Daren Shaw sold 1,000 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $213.43, for a total transaction of $213,430.00. Following the completion of the transaction, the director directly owned 23,726 shares of the company’s stock, valued at $5,063,840.18. The trade was a 4.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 19,073 shares of company stock worth $3,693,390 in the last quarter. Corporate insiders own 3.90% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.